期刊文献+

动脉粥样硬化患者血液中基质金属蛋白酶-9及其抑制物-1的基因表达 被引量:7

Gene Expression of the MMP-9 and TIMP-1 in the Blood of Patients with atherosclerosis
原文传递
导出
摘要 目的通过检测动脉粥样硬化(AS)患者血液中基质金属蛋白酶-9(MMP-9)与基质金属蛋白酶抑制物-1(TIMP-1)的基因表达水平,探讨AS发生的分子机制及预测因子。方法 AS患者120例为动脉硬化组,72例正常体检者为对照组。用实时荧光定量PCR(RT-PCR)检测其血液中MMP-9和TIMP-1 mRNA表达水平。结果 MMP-9和TIMP-1的RT-PCR产物序列与GenBank上人MMP-9 mRNA和TIMP-1基因片段完全一致。动脉硬化组的MMP-9基因表达水平高于对照组MMP-9基因表达水平,但差异无统计学意义(P>0.05)。动脉硬化组的TIMP-1基因表达水平低于对照组TIMP-1基因表达水平,差异有统计学意义(P<0.05)。MMP-9/TIMP-1基因表达定量比值,动脉硬化组高于对照组,差异有统计学意义(P<0.05)。结论 AS患者TIMP-1基因表达水平的降低与MMP-9/TIMP-1基因表达定量比值升高可能是AS发生的分子机制之一,二者一起可以作为AS发生的预测因子。 Objective To observe matrix metalloproteinase-9(MMP-9) and matrix metalloproteinase inhibitor-1(TIMP-1) gene expression in the blood of the patients with atherosclerosis(AS).Methods One hundred and twenty patients with AS hospitalized and matched with diagnostic criteria were enrolled into experimental group.Seventy two cases who had accepted normal physical examination were enrolled into as the control group.The level of expression of MMP-9 and TIMP-1 mRNA in both the groups were detected by real-time fluorescence quantitative PCR(RT-PCR) technology.Results The sequence of RT-PCR products of MMP-9 and TIMP-1 was consistent with their human genetic fragment in GenBank. The level of expression of MMP-9 mRNA in the experimental group was higher than that in the control group,but there was not significant difference between two groups(P〉0.05 ).The level of expression of TIMP-1 mRNA in the experimental group was significantly lower than that in the control group,and there was significant difference(P〈0.05).The ratio of expression of MMP-9 and TIMP-1 mRNA was higher in experimental group than that in the control group,there was significant difference(P〈0.05).Conclusion The level of TIMP-1 gene expression decresed and the ratio of MMP-9/TIMP-1 mRNA expression increased in patients with AS can be one of the molecular mechanisms of the triggering and promotion factors in the prosedure of AS.Both of them can be taken as independent predictors of As in patients.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2011年第1期118-120,123,共4页 Suzhou University Journal of Medical Science
基金 江苏省自然科学基金资助项目(BK2008117)
关键词 动脉粥样硬化 基质金属蛋白酶-9 基质金属蛋白酶抑制物-1 基因表达 atherosclerosis matrixmetalloproteinase-9 metalloproteinase-1 gene expression
  • 相关文献

参考文献11

  • 1Kuge Y, Takai N, Ishino S, et al. Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP) , matrix metalioproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis[J]. Biol Pharm Bull, 2007,30 (9) :1634 - 1640.
  • 2苏伟,高枫,龚少愚,张亦哲,陆曙.原发性高血压患者血清基质金属蛋白酶9与升主动脉弹性的关系[J].中华高血压杂志,2010,18(4):385-389. 被引量:12
  • 3于小红,瞿玲慊,钮红音,姜敏辉,刘毅.高血压病患者合并颈动脉粥样硬化与血清高敏C反应蛋白的相关性研究[J].苏州大学学报(医学版),2005,25(6):1038-1040. 被引量:3
  • 4Zureik M, Beaudeux JL, Courbon D,et al. Serum tissue inhibitors of metalloproteinases 1 ( TIMP-1 ) and carotid atherosclerosis and aortic arterial stiffness [J]. J Hypertens, 2005,23 (12) :2263 - 2268.
  • 5姚义琴,谢梅林,薛洁,张克平,朱路佳.阿司匹林调节小鼠腹腔巨噬细胞MMP-2/9和TIMP-1基因的表达及分泌[J].苏州大学学报(医学版),2009,29(3):422-425. 被引量:1
  • 6Jose RR, Ramachandran SV, Alexa SB, et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the framingham off- spring study[ J ]. J Stroke Cerebrovasc Dis,2008,17 ( 6 ) : 412 - 417.
  • 7Kumada M, Kihara S, Ouchi N, et al. Adiponectin speci- fically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages [J]. Circulation,2004,109 ( 17 ) : 2046 - 2049.
  • 8Galia ZS, Mmnwki M,Sakhova GK,et al. Enhanced exprsssion of vascular matrixmetallopo-teinases in vitro by cytokines and in regions of human atherosclerotic lesions [ J ]. Ann NY Acad Sci, 1995,748 ( 3 ) :501 - 507.
  • 9Galis ZS, Sukhova GK, Kranzhofer R, et al. Mactrophag foam cells fiom experimental atheroma constitutively produce matridegrading proteinase [ J ]. Proc Natl Acad Sci USA, 1995,92 (2) : 402 - 406.
  • 10Basu P, Sen U, Tyagi T, et al. Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function [J]. Vascular Health and Risk Management, 2010,6(3):215 - 228.

二级参考文献29

  • 1郑孝志,季平,茅红卫.高血压病患者升主动脉弹性的应变率评价[J].临床超声医学杂志,2007,9(2):88-90. 被引量:9
  • 2Mehta P. Aspirin in the prophylaxis of coronary artery disease[J]. Curr Opin Cardiol, 2002, 17(5):552-558.
  • 3Karna E, Palka JA. Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation [J]. Eur J Pharmacol, 2002, 443(1-3):1-6.
  • 4Murono S, Yoshizaki T, Sato H, et al. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein-1 through suppression of matrix metalloproteinase-9 expression[J]. Cancer Res, 2000, 60(9): 2555-2561.
  • 5Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly[J]. Circ Res, 2002, 90(3):251-262.
  • 6Galls ZS, Johnson C, Godin D, et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling[J]. Circ Res, 2002, 91(9):852-859.
  • 7Cho A, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury[J]. Circ Res, 2002; 91(9): 845-851.
  • 8Orbe J, Fernandez L, Rodriguez JA, et al. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions: relation to plaque features and vascular bed [J]. Atheroselerosis, 2003, 170(2):269-276.
  • 9Lemaitre V, Soloway PD, D'Armiento J. Increased medial degradation with pseudo -aneurysm formation in apolipoprotein E-knockout mice deficient in tissue in- hibitor of metalloproteinases-1[J]. Circulation, 2003, 107 (2):333-338.
  • 10Clark IM, Swingler TE, Sampieri CL, et al. The regulation of matrix metalloproteinases and their inhibitors[J], lnt J Biochem Cell Biol, 2008, 40(6-7):1362-1378.

共引文献13

同被引文献95

  • 1郭士金.急性冠脉综合征患者易损斑块与血清MMP-9水平的相关性研究[J].实用医技杂志,2008,15(11):1373-1375. 被引量:15
  • 2魏莉,徐盈.基质金属蛋白酶9在老年肺癌中的表达及临床意义[J].中国老年学杂志,2014,34(1):89-90. 被引量:8
  • 3谭元生,宋雪云,谭胜真,唐莹,范愈记,张稳.复方七芍降压片治疗高血压病的临床研究[J].中成药,2005,27(7):795-798. 被引量:9
  • 4屈宝泽,王化洲.血管内皮功能与冠心病发生与发展[J].中国临床康复,2005,9(35):132-134. 被引量:12
  • 5徐叔云.药理实验方法学[M].北京:人民卫生出版社,1999:1535.
  • 6W(a)gs(a)ter D,Zhu C,Bj(o)rkegren J,et al.MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-) Apob(100/100) mouse[J].Int J Mol Med,2011,28 (2):247-253.
  • 7Newby AC. Matrix metalloproteinases regulate migration,proliferation,and death of vascular cells by degrading matrix and non-matrix substrates[J].Cardiovascular Research,2006,(03):614-624.
  • 8Suh SJ,Kim JR,Jin UH. Deoxypodophyllotoxin,flavolignan,from AnthAnth riscus sylvestris Hoffm.inhibits migration and MMP-9 viaMAPK pathways in TNF-alpha induced HASMC[J].Vascular Pharmacology,2009,(01):13-20.
  • 9Lee YH,Kim TY,Hong YM. Metalloproteinase-3 genotype as apredictor of cardiovascular risk in hypertensive adolescents[J].Korean Circ J,2009,(08):328-334.
  • 10Murphy G,Nagase H. Progress in matrix metalloproteinase research[J].Molecular Aspects of Medicine,2008,(05):290-308.doi:10.1016/j.mam.2008.05.002.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部